Media » Webinar “Introducing bictegravir and licensing opportunities through the Medicines Patent Pool”

Webinar “Introducing bictegravir and licensing opportunities through the Medicines Patent Pool”

The Medicines Patent Pool organised a webinar “Introducing bictegravir and licensing opportunities through the Medicines Patent Pool” on Wednesday 13 December.

Agenda:

  • Welcome & introduction: Sandeep Juneja, Business Development Director, MPP
  • Bictegravir and the STR (B/F/TAF): Thomas Edinger, PhD, Medical Scientist Virology, Gilead Sciences
  • Bictegravir manufacturing considerations: Ken Kent, Vice President, Manufacturing, Gilead Sciences
  • Overview of MPP-Gilead Licence: Chan Park, General Counsel, and Maica Trabanco, Associate Counsel, MPP
  • Overview of MPP EOI portal: Sandeep Juneja, Business Development Director and Hannah Moak, Business Development Manager, MPP
  • Q&A

Presentations:

Recording:

More information on the Expression of Interest process and access to the platform

This website uses cookies to ensure you get the best experience on our website. Learn More